Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 March 2006:
Vol. 311. no. 5768, pp. 1716 - 1717
DOI: 10.1126/science.1120953
Prev | Table of Contents | Next

Policy Forum

SCIENCE AND LAW:
Intellectual Property and Human Embryonic Stem Cell Research

Jeanne F. Loring and Cathryn Campbell

The history of U.S. stem cell patents illuminates their potential as research barriers and possible vulnerabilities.

J. F. Loring is at the Burnham Institute for Medical Research, La Jolla, CA 92037, USA. C. Campbell is with McDermott Will & Emery, LLP, Washington, DC 90005, USA. E-mail: jloring{at}burnham.org (J.F.L.) and ccampbell{at}mwe.com (C.C.).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Patenting human pluripotent cells: balancing commercial, academic and ethical interests.
G. Bahadur and M. Morrison (2009)
Hum. Reprod.
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)